ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SBTX Skinbiotherapeutics Plc

15.875
0.00 (0.00%)
26 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 15.875 15.50 16.25 15.875 15.875 15.88 165,889 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 132k -2.84M -0.0125 -12.70 35.89M
Skinbiotherapeutics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherapeutics was 15.88p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 7.25p to 19.375p.

Skinbiotherapeutics currently has 226,086,285 shares in issue. The market capitalisation of Skinbiotherapeutics is £35.89 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -12.70.

Skinbiotherapeutics Share Discussion Threads

Showing 27076 to 27098 of 27950 messages
Chat Pages: Latest  1094  1093  1092  1091  1090  1089  1088  1087  1086  1085  1084  1083  Older
DateSubjectAuthorDiscuss
24/10/2024
06:34
This is the sort of thing that's preferable prior to an RNS. But just after one is a bit of an issue
putinaire
23/10/2024
18:54
hows syme coming along ?

zero soon i see

rackersthedon
23/10/2024
18:45
RNS Translation

‘No reason for share price movement’
Translation: What is going on ?

‘ No rationale for share price movement ‘
Translation: We don’t understand, we have no clue, help

‘ to the Board's knowledge, there is no reason behind it.’
Translation: ‘We don’t understand that more selling pressure than buying, can be a reason for a share price to be marked lower ‘

Imo

kreature
23/10/2024
18:25
‘ No rationale for share price movement ‘

For balance, I’d say the rational could be….
1. Profit taking following a 50% share price rise
2. Uncertainty concerning the Opti situation
3. Investors understanding that turnover is not net profit
4. Just a general sense of binaryness in the air.

In my opinion, as always.

kreature
23/10/2024
18:15
RNS sub titles looks a bit desperate given stated twice below, imv tbf. In fairness, I bet some systems just don’t work unless the share price remains within a distribution zone ? Also tbf turnover is not earnings right ?

‘No reason for share price movement’
‘No rationale for share price movement ‘

kreature
23/10/2024
15:43
The Group notes the movement in the share price, but to the Board's knowledge, there is no reason behind it.

Must have been talking about the rise to 88p

putinaire
23/10/2024
15:32
When they announced dermatonics it sank nearly 60%

I hope this is more exciting

putinaire
23/10/2024
15:24
"The Group, through acquisition and recent fund raisings, is on a strong financial footing, and our projected annualised turnover for FY25 is significantly increased on the previous year.

Lol

putinaire
23/10/2024
15:23
In the meantime, we have recently updated the market on the Croda/SkinBiotix partnership which has entered the commercial stage and is moving apace, and we continue to receive positive feedback and retention from our AxisBiotix-Ps customers.

Lol

putinaire
23/10/2024
15:23
"The Group notes the movement in the share price, but to the Board's knowledge, there is no reason behind it."

Are they dim? All the selling was for no reason?

putinaire
23/10/2024
15:22
Whats that in English?


23 October 2024, SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, is pleased to report that the integration of Bio-Tech Solutions Ltd ("BTS"), recently acquired for £1.25m, is well advanced, and with Dermatonics, it is complete.

putinaire
Chat Pages: Latest  1094  1093  1092  1091  1090  1089  1088  1087  1086  1085  1084  1083  Older

Your Recent History

Delayed Upgrade Clock